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Abstract: The aim of this study was to determine the impact of tumor volume on generalized behavior, pain perception, and serum
C-reactive protein (CRP) in dogs with canine transmissible venereal tumors (CTVTs). Pain scoring was performed using the
Glasgow Composite Measure Pain Scale Short-Form. Cytomorphology of the tumors was studied through fine-needle aspiration and
histopathology. Molecular identification of CTVTs was carried out using PCR assays based on LINE-1/c-myc. Hematological profiles
including complete blood count and CRP were analyzed using an automatic hematology analyzer and immunoturbidimetric assays,
respectively. Chi-square and regression analysis statistics were used for data analysis. Results of the study revealed a statistically
significant (R2 = 0.798) impact of tumor volume on pain scores in corresponding individuals. Hematological parameters and serum
CRP values were observed in normal ranges and did not reveal any significant association with tumor volume. All of the samples were
found positive for LINE-1/c-myc molecular rearrangement, revealing a 552-bp PCR product. On the basis of cytology tumors were
differentiated into plasmacytoid, lymphocytoid, and mixed types. No significant association could be observed among cytological types
and sex of the individuals. It may be concluded that increasing tumor size may result in localized pain and mild behavioral alterations in
affected dogs. However, hematology profiles and serum CRP levels are independent of the localized tumor proliferation.
Key words: Pain scores, C-reactive protein, hematology, cytology, histopathology

1. Introduction
Cancer is generally not a contagious disease; however, in
a few conditions, tumor cells may attain the substantial
capacity to disseminate among the individuals of a
population. Canine transmissible venereal tumors
(CTVTs) (1) and Tasmanian devil facial tumor type
1 and type 2 (2) occur in dogs and Tasmanian devils,
respectively, and are typical examples of contagious
tumors. CTVT is frequently witnessed in dogs living in
close contact with each other, in wild and stray dogs that
show significant sexual activity (3). Most commonly it is
transmitted through sexual intercourse but it could also
transmitted through licking, sniffing, and biting of tumoraffected areas (4). Venereal tumors are mostly localized
and grossly seen as single or multiple, large or small, soft
or friable, pedunculated, nodular, or papillary and tubular
masses (5).
C-reactive protein (CRP) is an essential prognostic
marker in several malignant conditions (6,7) such as
esophageal cancer (8), colorectal cancer (9), pancreatic

cancer (10), lung cancer (11), and breast cancer (12).
Therefore, CRP in correlation with leukocytic patterns
is a determinate biomarker that has the potential to
increase the predictive efficacy of prognostic models
(13). Moreover, treatment of pain is a necessary aspect of
clinical practices and requires the ability to recognize and
assess pain in animals (14).
Therefore, the aim of the study was to determine the
impact of tumor volume on generalized behavior, pain
perception, and serum CRP levels in CTVT-affected dogs
clinically diagnosed through cytological examination and
PCR.
2. Materials and methods
2.1. Source of samples
The samples were collected from the Pet Clinic of the
University of Veterinary and Animal Sciences of Lahore. A
total of 30 dogs of different breeds, ages, and weights were
included in the present study that fulfilled predetermined
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criteria. Inclusion criteria were individuals not spayed or
neutered, exhibiting clinical signs of CTVT, not exhibiting
signs of any other fatal disease, and not having any
reoccurring tumors (15).
2.2. Pain assessment
Assessments of pain, spontaneous and evoked behaviors,
interactions with the animal, clinical observations, and
behavioral changes in the individual animals were made
according to a structured questionnaire following the
standard protocols described for the Glasgow Composite
Measure Pain Scale Short-Form (14).
2.3. Hematological analyses
Whole blood was collected from the respective individuals
from the cephalic vein at the time of surgical procedure
and transferred to EDTA-coated and clot activator
vacutainers separately as described by Thrall et al. (16).
Hematological parameters including total erythrocyte
count (TEC), hemoglobin (Hb), packed cell volume
(PCV), total leukocytic count (TLC), and differential
leukocytic count (DLC) were analyzed using an automatic
hematology analyzer (Beckman Coulter Ac-T diff)
by standard procedures. The CRP concentration was
determined by immunoturbidimetric method using
a Randox Canine CRP Kit (Catalogue No. CP2798)
according to the manufacturer’s instructions. Analyses
of the samples were performed in duplicate. Prior to the
processing of all samples, the equipment was calibrated
with three levels of calibrators that allowed the calibration
of the automated equipment. A reference material was
used in order to minimize the occurrence of errors. The
formation of antigen–antibody complexes was evaluated
with a spectrophotometer at 340 nm for 25 s.
2.4. Tumor investigations
Tumor volume was calculated before the time of surgical
excision using the following formula: volume = L × W ×
H × π/4 (L: length; W: width; H: height in centimeters),
as previously described (17). A 21-gauge hypodermic
needle connected to a 10-mL disposable syringe was
used for aspiration of tumor cells. The tissue aspirate was
smeared to make a monolayer of CTVT on a microscopic
slide (18). Cytomorphological analysis was completed by
counting at least 100 cells from each sample. The observed
samples from each slide were categorized as lymphocytoid
or plasmacytoid according to cell morphology. Tumor
samples were obtained by surgical removal under aseptic
conditions. Pain management was done by injecting 5 mL
of 2% lidocaine HCL locally at the site of excision (19).
Each sample was divided into two parts; one part was
stored at –20 °C for molecular studies while the other part
was fixed in 10% neutral buffered formalin, dehydrated
by a series of graded alcohols, cleared through xylene,
embedded in paraffin, and sectioned for histopathological
analyses (20).
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2.5. Molecular identification
Fresh frozen samples were used for the molecular
identification of extracted DNA. The Gene-Jet Genomic
DNA Purification Kit (Catalogue No. K0722-250, Thermo
Fischer Scientific) was used for the DNA extraction with
modifications for tissue DNA isolation. Canine somatic
DNA from skin biopsy was used as a negative control. A
NanoDrop ND-1000 UV spectrophotometer at 260 nm
was used to check purity and concentration of the DNA.
Myc S-2 and LINE-AS1 primers were used to identify a
552-bp segment starting from the 5′ end of the LINE-1
insertion outside the first exon of c-myc (21):
MycS-2: ATTCCTACGAATGAATGATTGGCCAGA
LINE AS-1: GACACATAGATCAGTGGAACAGAAT
DNA was amplified using a commercially available
PCR master mix (Catalogue No. K0171, Thermo
Scientific). The samples were processed in the thermocycler
(programmable thermal cycler PTC-6) as follows: initial
denaturation at 94 °C for 5 min; followed by 35 cycles of
denaturation at 94 °C for 1 min, annealing at 64 °C for 50 s,
and extension at 72 °C for 1 min; and then final extension
at 72 °C for 5 min. Thereafter, 10 µL of each PCR product
was gel electrophoresed at 100 V for 20 min. The size of the
PCR products was compared against a DNA ladder marker.
The agarose gel was then visualized and photographed
under a UV transilluminator (Vilber Lourmat).
2.6. Statistical analysis
All statistical analyses were performed using GraphPad
Prism 7 (22). The influence of tumor volume on Glasgow
Composite Measure Pain Scale Short-Form scores and
serum levels of CRP in affected individuals was analyzed
by regression analysis. Hematological parameters were
described by descriptive statistics. Association between
cytological type of CTVT and sex of the individual was
tested by the chi-square test. The level of significance was
0.05.
3. Results
Median tumor volume observed in the study was 20.67 cm3.
Results of the regression analysis revealed a statistically
significant (R2 = 0.798, P < 0.0001) impact of tumor
volume on pain scores in corresponding individuals. On
the other hand, serum CRP values did not reveal any
significant (P = 0.0641) association with tumor volume
and were observed to be in normal ranges (3.587 ± 1.37
mg/L). Figure 1 shows the line fit plot of the observed data.
Values of the hematological parameters including TEC,
Hb, PCV, TLC, and DLC were in normal ranges. The Table
shows the values of various hematological parameters.
Cytological examination of tumor masses through
fine-needle aspiration revealed the presence of frequently
vacuolated round cells having large nuclei, frequent mitotic
figures, and noticeable nucleoli, supporting the diagnosis of
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Table. Values of hematological parameters of the CTVT-affected
dogs.
Parameter

Value (mean ± SD)

RBCs (10 /µL)

7.067 ± 0.712

Hb (g/dL)

15.923 ± 1.047

6

PCV (%)

50.257 ± 5.615

WBCs (10 /µL)

10.284 ± 1.970

Neutrophils (103/µL)

6.66 ± 1.34

Lymphocytes (103/µL)

2.67 ± 0.59

Monocytes (103/µL)

0.63 ± 0.25

Eosinophils (10 /µL)

0.28 ± 0.06

Basophils (103/µL)

0.035 ± 0.01

3

3

Figure 1. Line fit plot of serum CRP values in relation to CTVT
tumor volume.

CTVT. Cytological types were classified into lymphocytic,
plasmacytoid, and mixed populations depending upon
the physical characteristics of the principal cell type. The
lymphocytic group included cells count of 60% or more
with round morphology, some degree of finely granular
cytoplasm, and round nucleus having rough chromatin
along with vacuoles present in the outside edges of the cell.
The plasmacytoid group included 60% or more ovoid cells,
having abundant cytoplasm (low nucleus to cytoplasm
ratio) and centrally located nucleus. Those samples in
which either cell morphology did not surpass 59% of the
total cells were categorized into the mixed type group.
Out of a total of 30 samples, there were more females
represented (73.33%) than male dogs (26.67%). The highest
frequency was observed for plasmacytoid tumors (30%),
followed by mixed tumors (23.33%) and the lymphocytoid
type (20%), in female dogs. In males, the frequency of
plasmacytoid tumors was comparatively higher (13.33%),
followed by lymphocytoid and mixed types, both of
which contributed 6.67%, respectively. Collectively, the
plasmacytoid cytology was the most common, with 43.3%
of samples, followed by mixed (30%) and lymphocytic
(26.6%). However, statistically no significant (P < 0.05)
association could be observed among the cytological types
and sexes of the individuals.
Histopathological studies revealed large round or
polyhedral cells with elliptical to circular nuclei having
coarsely accumulated chromatin; most nuclei of cells had
single, prominent, and bluish nucleolus. High nuclear
: cytoplasmic ratio was observed in most of the cases.
Cytoplasm was scanty, light blue to colorless (poorly
stained), and finely granular and contained distinct clear
vacuoles. However, on the basis of histological patterns
the samples were differentiated into progression and

regression phase tumors. The progression phase tumors
revealed closely packed tumor cells along with a mild
subcapsular inflammatory infiltrate, while plasma cells
and tumor-infiltrating lymphocytes were notable in
regression phase tumors. Nuclei of the neoplastic cells had
eccentric, distinctive, and violet nucleoli. The neoplastic
cells were structured diffusely or in the form of threads
encapsulated by connective tissue. Figure 2 illustrates the
needle aspiration cytology and histopathological patterns
of tumorous masses.
Genomic amplification of the tumor samples through
MycS-2 and LINE AS-1 primers produced a region of
552 bp characterizing the LINE-1 transposon insertion
in the c-myc gene. All of the tumor samples were found
positive for LINE-1/c-myc molecular rearrangement.
Figure 3 shows the agarose gel electrophoresis pattern of
an amplified product with approximately 552 bp from a
CTVT.
4. Discussion
The importance of efficient pain alleviation for animals is
being increasingly accepted in the veterinary profession.
However, CTVT has remained neglected regarding
pain management in combination with antiproliferative
therapy. To our knowledge, the current study is the first
to investigate the association of tumor volumes with pain
scores in affected dogs. Reid et al. (14) demonstrated the
cut-off points of pain scores as 7, 7, and 8 for analgesia.
Moreover, the dogs that were not considered to require
analgesia revealed median pain scores of 4, 2.5, and 3
with the Dublin, Glasgow, and North Carolina scores,
respectively. The individuals with observed tumor
volumes in the present study revealed varying degrees of
pain but most animals did not require critical analgesia
according to the guidelines of Reid et al. (14). In the
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Figure 2. a- Mixed type cells in Giemsa-stained aspiration smear, arrow showing plasmacytoid cells while arrowheads show lymphocytoid cell type (100×). b- Histopathological slide of progression phase tumor having frequent round cells with lesser amount of connective tissue (10×, H&E stain). c- Regression phase tumor revealing fewer round to polyhedral shaped cells along with greater amounts of
connective tissue. Arrows show numerous tumor-infiltrating lymphocytes in the tumor microenvironment (40×, H&E stain). d- Typical
round to polyhedral cells having vacuolated cytoplasm, larger nuclei, and single nucleoli (100×, H&E stain).

present study, frequency of CTVT was higher in females
(73.33%) compared to male dogs (26.67%). The findings
are in accordance with the studies of Araujo et al. (23),
who reported a higher frequency observed in females
compared to males. The histopathological findings of
the current study are also in accordance with those of
the studies of Ulcar et al. (24) and Murchison (25), who
described pleomorphic round to ovoid shaped cells, with
eccentrically amphophilic round to ovoid nuclei with
moderate amounts of cytoplasm. Furthermore, all tumor
samples were confirmed as CTVT through LINE-1/cmyc-based PCR. The findings of the present study are in
accordance with the previous studies performed by Liao et
al. (21) and Setthawongsin et al. (1), who used similar sets
of primers to amplify the 552-bp LINE-1/c-myc product
for the confirmation of CTVT.
Hematological values observed in the present
study were in normal ranges when compared with the
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previously published reference values (16). The normal
values are indicative of the absence of any discrepancy
in hematopoietic as well as in immune functioning (18).
The findings are in accordance with previous studies
conducted to find the association between elevated levels
of biomarkers and several organ-specific malignancies
(26–28). Proteins (matrix metalloproteinase-7 and matrix
metalloproteinase-12) are generally related to tumor
growth and contribute to sustained proliferation and
invasion. CRP has been extensively studied as a biomarker
of malignancies (26,29) and is supposed to support the
tumor microenvironment by inducing tumor-promoting
inflammation (30). Similarly, in canines, elevated levels of
CRP have consistently been attributed to increased tumor
progression and poor prognosis (31). However, the values
of serum CRP levels in the CTVT-affected dogs were
observed to be in the normal ranges and did not reveal any
statistical associations with tumor volumes. The values are
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Figure 3. Agarose gel electrophoresis pattern. L: Molecular ladder marker of 100 bp,
Lanes 1–6: 552-bp LINE-1/c-myc amplified PCR products from CTVT samples; Lane
7: negative control.

in accordance with the studies of Hillström et al. (32), who
previously studied serum levels of CRP in normal canids
using the immunoturbidimetric method. Furthermore,
normal ranges of the total leukocyte count and differential
leukocyte count observed in the present study support the
normal levels of serum CRP levels (33). Lack of association
between serum CRP levels and CTVT volume along with
the normal hematological ranges in the present study are
indicative of localized tumor proliferation with reduced

risks of progression and fair prognosis. However, the role
of CRP in metastasized conditions of such tumors is so far
unstudied.
It could be concluded that CTVTs with increased
volumes remain a source of localized pain and mild
behavioral alterations in affected dogs. However, serum
CRP levels are independent of the localized proliferation
of tumor masses having different cytomorphological and
histological patterns.
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